India Pharma Awards 2021
TCS ADD™ Regulatory platform won the India pharma awards 2021
Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
Faster and in-compliance drug registration
Chris Lee, VP, Global Regulatory Affairs and Quality Management, Merck, explains how TCS, through TCS ADD™ Regulatory, is creating solutions beneficial not only to Merck but to the overall industry in terms of accelerating the rollout of new drugs.
You have these already downloaded
We have sent you a copy of the report to your email again.
TCS ADD™ Regulatory platform won the India pharma awards 2021
Monitoring of regulatory processes via real-time alerts
50% reduction in submission management activities
Up to 20% reduction in overall regulatory cycle times
Operational inefficiencies due to the lack of end-to-end traceability, effort-intensive tracking and reporting across projects, and associated plans lead to submission misses and non-compliance.
Stringent regulatory compliance and submission standards by authorities have increased the risk of non-compliance and higher costs. In most cases, the existing regulatory intelligence platform is devoid of cognitive intelligence. Also, project planning is highly complex in nature and lacks self-intuitiveness.
Siloed views and gaps in regulatory submission status, lack of visibility and reuse of components, operational inefficiencies, and cumbersome program management have led pharmaceutical organizations to adopt AI/ML-driven technology solutions.
Enables the tracking of integrated and actionable regulatory processes across all operating systems, including mobile apps. The module also provides automated alerts and notifications. In addition, it provisions a rich and easy-to-use reporting dashboard and visualization as well as facilitates a template-driven submission planning and customization that allows precise planning at milestone-task-component level
Facilitates intelligent redaction, data anonymization, review, quality control (QC), and formatting of regulatory content. The module also facilitates AI-enabled label discrepancy identification and provides region and country-specific archival analytics and reports
Provides a repository of internal and external regulatory data providing meaningful insights; provisions a smart search engine for Response to Query (RTQ) and market intelligence that comprises a centralized repository of domain ontologies, and accelerates the creation of regulatory responses and submissions
Integrates and reuses data, documents, and templates from multiple sources through SmartAuthor, thereby automating document creation and reducing submission discrepancies
compliance to regulatory timelines
adherence to quality and submission
accountability of submissions
savings in program management
reduction in monthly reporting efforts
reduction in Health Authority (HA) submission delays
Swipe LeftSwipe RightThe pandemic resulted in unprecedented collaboration and agility across the pharma ecosystem. With rapid and safe roll-out of drugs of utmost importance, pharma organizations world-over are harnessing the power of AI and analytics to accelerate the regulatory submission process and launch new drugs for patients.
Rachna Malik
Global Head, TCS ADD™ Platforms
Learn how we can help you bring drugs to the market faster.
Talk to our experts